Laurus Labs Future Growth
Future criteria checks 4/6
Laurus Labs is forecast to grow earnings and revenue by 47.1% and 13.4% per annum respectively. EPS is expected to grow by 46.8% per annum. Return on equity is forecast to be 16.3% in 3 years.
Key information
47.1%
Earnings growth rate
46.8%
EPS growth rate
Pharmaceuticals earnings growth | 18.7% |
Revenue growth rate | 13.4% |
Future return on equity | 16.3% |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 74,728 | 9,022 | 5,000 | 11,735 | 5 |
3/31/2026 | 68,277 | 7,303 | 2,388 | 9,983 | 14 |
3/31/2025 | 58,957 | 4,430 | 2,461 | 8,982 | 14 |
3/31/2024 | 50,408 | 1,606 | -126 | 6,657 | N/A |
12/31/2023 | 49,821 | 1,879 | N/A | N/A | N/A |
9/30/2023 | 53,320 | 3,678 | 2,870 | 12,248 | N/A |
6/30/2023 | 56,834 | 5,637 | N/A | N/A | N/A |
3/31/2023 | 60,406 | 7,901 | 37 | 9,939 | N/A |
12/31/2022 | 60,845 | 9,176 | N/A | N/A | N/A |
9/30/2022 | 55,684 | 8,683 | 13 | 8,393 | N/A |
6/30/2022 | 51,960 | 8,374 | N/A | N/A | N/A |
3/31/2022 | 49,356 | 8,275 | 343 | 9,111 | N/A |
12/31/2021 | 49,227 | 8,937 | N/A | N/A | N/A |
9/30/2021 | 51,823 | 10,128 | -1,705 | 7,112 | N/A |
6/30/2021 | 51,177 | 10,532 | N/A | N/A | N/A |
3/31/2021 | 48,135 | 9,836 | 442 | 7,330 | N/A |
12/31/2020 | 42,407 | 7,971 | N/A | N/A | N/A |
9/30/2020 | 36,819 | 5,977 | 1,548 | 5,427 | N/A |
6/30/2020 | 32,555 | 4,120 | N/A | N/A | N/A |
3/31/2020 | 28,317 | 2,553 | 1,252 | 3,474 | N/A |
12/31/2019 | 26,277 | 1,883 | N/A | N/A | N/A |
9/30/2019 | 24,276 | 1,326 | 1,613 | 3,538 | N/A |
6/30/2019 | 23,035 | 923 | N/A | N/A | N/A |
3/31/2019 | 22,919 | 938 | 434 | 2,977 | N/A |
12/31/2018 | 22,170 | 957 | N/A | N/A | N/A |
9/30/2018 | 21,665 | 1,127 | N/A | N/A | N/A |
6/30/2018 | 21,168 | 1,453 | N/A | N/A | N/A |
3/31/2018 | 20,562 | 1,676 | -486 | 3,425 | N/A |
12/31/2017 | 19,687 | 1,917 | N/A | N/A | N/A |
9/30/2017 | 19,954 | 2,019 | N/A | N/A | N/A |
6/30/2017 | 19,733 | 2,014 | N/A | N/A | N/A |
3/31/2017 | 19,046 | 1,881 | N/A | 3,320 | N/A |
3/31/2016 | 17,776 | 1,337 | N/A | 1,820 | N/A |
3/31/2015 | 13,266 | 684 | N/A | -647 | N/A |
3/31/2014 | 11,597 | 972 | N/A | 1,212 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 540222's forecast earnings growth (47.1% per year) is above the savings rate (6.7%).
Earnings vs Market: 540222's earnings (47.1% per year) are forecast to grow faster than the Indian market (17.5% per year).
High Growth Earnings: 540222's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 540222's revenue (13.4% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: 540222's revenue (13.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 540222's Return on Equity is forecast to be low in 3 years time (16.3%).